Comparative study between simultaneous and two-stage revascularization in patients with multi -segmental lower limbs arterial occlusive disease | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Al-Azhar International Medical Journal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Article 11, Volume 1, Issue 5, May 2020, Page 204-211 PDF (855.4 K) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Document Type: Original Article | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DOI: 10.21608/aimj.2020.26229.1174 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 View on SCiNiTO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Authors | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Ahmed El sayed Afify  1; Mahsob Morad Amin2; Mohammad Alsagher Alhewy3
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1Vascular surgery department,faculty of medicine,Alazhar university,cairo,egypt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2Vascular surgery department, faculty of medicine, Alazhar university, Cairo, Egypt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3Vascular surgery department, faculty of medicine, Alazhar university, assiut, Egypt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Abstract | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Background: Peripheral arterial disease (PAD) is defined as a slowly progressing, occlusive vascular disease of the extremities primarily due to atherosclerosis which can involve vasculitis and thrombosis and diagnosed by an ankle-brachial index (ABI) less than 0.9. It may lead to intermittent claudication (IC) and with progression of the disease may lead to critical limb ischemia (CLI). Aim of the work: to compare the results between simultaneous revascularization of all level arterial lesions versus staged revascularization of the proximal or distal lesions regarding limb salvage rates, midterm primary patency rates, and secondary patency rates in multi-segment peripheral arterial disease Study Design and methodology: randomized comparative study. We randomly divided patients into two groups. Group A (20 patients: treated by total revascularization of all arterial lesions affecting the target limb) and Group B (20 patients: treated staged revascularization). Results: success rate after total revascularization (group A) reaching 82.5% success rate, success rate after staged revascularization (group B) reaching 65% success rate from inflow cases and 66.7% of the outflow repair. We achieved a limb salvage rate of 67.5% (27 patients). The difference between the groups was not statistically significant regarding amputation rates (P=0.99). Primary patency rate at 12 months was not significantly higher in group A than in group B (65% vs. 50%; P =0.98). Wound closure was statistically higher in group A than in group B (P=0.04). Reintervention was needed in 12 patients owing to restenosis or total occlusion of the treated lesions presenting with either lost pulses, rest pain, or deterioration of the wound healing. The secondary patency rates were non statistically significant between group A and group B at 12 months (3 patients 60%, 2 patients 28.6%) (P=0.56). Hospital mortality was 5% in Group A and 10% in Group B. Group A showed lower amputation rate but non-significantly different with group B (P=0.5). Conclusion: We conclude that multi-segmental reconstructions for multilevel occlusive arterial disease is a safe and effective method of treatment in the presence of CLI. Correction of the proximal lesions only cannot be considered satisfactory especially in patients presenting with tissue loss as it is usually associated with inferior patency rates and low overall limb salvage rates. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Keywords | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Peripheral arterial disease; Angioplasty; open surgical repair; staged revascularization | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Supplementary Files
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Full Text | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Peripheral arterial disease (PAD) is defined as a slowly progressing, occlusive vascular disease of the extremities primarily due to atherosclerosis which can involve vasculitis and thrombosis and diagnosed by an ankle-brachial index (ABI) less than 0.9. It may lead to intermittent claudication (IC) and with progression of the disease may lead to critical limb ischemia (CLI). 1 The incidence of PAD is increasing worldwide due to an overall increase in diabetes, obesity, and other cardiovascular disorders.2 Importantly, the incidence of PAD will continue to increase, as the condition has historically been diagnosed in elderly populations, which are also rising worldwide.3 Critical limb ischemia is the most advanced stage of peripheral arterial occlusive disease. The prognosis is poor, with amputation rates up to 30 % and mortality up to 25% after 1 year.1 Only one out of every four to five patients with PAOD will be symptomatic. The most common clinical manifestation of PAOD is intermittent claudication. It is defined as ischemic pain occurring during exercise, which is quickly relieved with rest.4
Patient and Methods Patients: This comparative study was conducted in the vascular surgery department at Al-Azhar university hospitals starting from April 2018. The study included 40 patients (20 patient was treated by simultaneous total revascularization & 20 patient was treated by staged revascularizations) suffering from multi-segment peripheral arterial disease. The 40 patients divided in to 2 main groups:- Group A: This group included 20 patients with multi segmental arterial disease. For whom simultaneous total revascularization of all documented arterial lesions was done. Group B: This group included also 20 patients with multi segmental arterial disease. For whom staged revascularizations was done. Simultaneous or staged revascularization of all documented arterial lesions affecting the target limb with tissue loss and rest pain by endovascular treatment or by surgical repair. All the patients subjected to the inclusion criteria mentioned below. Ethical committee had been obtained in all patients. Inclusion criteria: Age over 18, Symptomatic, atherosclerotic multi-level arterial lesion, Critical lower limb ischemia (persistent rest pain of more than two weeks duration or ulcers or tissue loss or gangrene of one or more toes or ankle brachial Pressure Index (ABPI) <0.4, or peak systolic velocity (PSV)> 300 cm per sec) and Informed consent was provided. Exclusion criteria: Acute limb ischemia, Presence of a metastatic malignancy, or other disease that limits life expectancy, Previous endovascular or surgical treatment of the affected side, Inability or unwillingness to complete with the follow up schedule, Pregnancy or breast-feeding, Severe renal failure or Aneurysm of the abdominal aorta. Methods: After Informed written consent, patients was subjected to the following: Clinical evaluation. Duplex US and CT angiography. We randomly divided patients into two groups. Group A (20 patients: treated by total revascularization of all arterial lesions affecting the target limb) and Group B (20 patients: treated staged revascularization). In certain conditions we only able to treat the proximal lesions leaving the more distal lesions without intervention. These conditions include extended time of procedure, use of large amount of contrast or bad general condition of the patient during or after the procedure. Each group treated by angioplasty with or without stenting or by bypass surgery by using polytetrafluoroethylene grafts or saphenous graft. Followup and assessment: The patients was examined at the time of randomization, and after 1 month, 3 months, 6 months and 1 year. At the initial visit, medical history obtained, clinical, duplex and CT angiography was performed. Clinical improvement was documented before discharge and at subsequent outpatient visits. Wound closure and limb salvage are our primary endpoint. Clinical improvement was judged by palpable peripheral pulse, increase of claudication distance, disappearance of rest pain, wound healing, and limb salvage. The results obtained were statistically evaluated by SPSS 20. The study was approved by the Ethics Board of Al-Azhar University.
RESULTS The present study was conducted on 40 patients, 22 males (55 %) and 18 females (45 %). Figure 1 shows this distribution. Age of patients was 60.7±12.35 in total revascularization group and 66.2±11.24 in Staged revascularization (p>0.05). Their age ranged between 40 years and 80 years with a mean age of 60.7±12.35.
Figure (1) Distribution of the studied patients regarding their sex. The associated comorbidities are shown in Table (1)
Table (1) The associated diseases & risk factors in the patients
Symptoms and signs of patients included in this study included Rest pain, Ischemic Ulcers, Gangrene of Toe, Heel or Forefoot as shown in Table (2).
Table (2) Symptoms and signs of patients included in this study
II-Lesion characterization: A total number of 56 multi-segmental reconstructions were performed for 40 patients (sixteen had bilateral procedures) for treatment of critical limb ischemia due to multi segmental occlusive arterial disease. In 20 cases, revascularization was performed in one stage (Group A) and in 20 cases - as a two-stage procedure (Group B) Antegrade approach was used in 17 (70.8%) patients, divided into ipsilateral femoral access in 10 patients and brachial access in 7 patients (using long sheath), whereas contralateral access with cross-over sheath was used in 7 (29.2) patients. The lesions were crossed intraluminal in 10 (41.7) patients and subintimal in 14 (58.3) patients. Stents were used in 12(50%) patients.
Group A: (Total revascularization)
Table (3) Lesion characterization and interventions of group A
Group B: (Staged revascularization)
Table (4) Lesion characterization and interventions of group B
Table (1) Procedure time (hours)
Table (2) Hospital stay time (days)
Procedure (Technical) outcome: Success rate: Success rate after total revascularization (group A) was 82.5% and 65% after staged revascularization (group B) from inflow cases and 66.7% of the outflow repair. Procedure time (hours): Mean operation time was calculated for each procedure and exact numbers are shown in Hospital stay time (days): Mean hospital stay was calculated for each procedure and exact numbers are shown in Antegrade approach was used in 17 (70.8%) patients, divided into ipsilateral femoral access in 10 patients and brachial access in 7 patients (using long sheath), whereas contralateral access with cross-over sheath was used in 7 (29.2) patients. The lesions were crossed intraluminal in 10 (41.7) patients and subintimal in 14 (58.3) patients. Stents were used in 12(50%) patients.
Clinical outcome:- Limb salvage We achieved a limb salvage rate of 67.5% (27 patients). With 15 patients (75%) in group A and 12 patients (60%) for group B and a major amputation rate of 32.5% (13 patients) over 1-year follow-up period Figure (1).
Figure (1) limb salvage rate over one year period
There were two limbs lost in the early postoperative period in Group A (10%) due to thrombosis of the grafts and advanced gangrene of the foot. In Group B, three limbs were lost during the first month after operation (15%). In the remote postoperative period, limb salvage was 75% after 12 months in Group A and 60% in Group B. During the observation period, a total number of 5 limbs were lost (25%) in Group A and 8 (40%) in Group B. The difference between the groups was not statistically significant (P=0.99).
Primary patency rate: -
Primary patency rate at 12 months was not significantly higher in group A than in group B (65% vs. 50%; P =0.98)
Figure (2) Primary patency rate
The primary graft patency rate was 65% in Group A and 50% in Group B after one year. The difference between the groups was not statistically significant (P=0.98).
Wound closure was statistically higher in group A than in group B (P=0.04).
Figure (3) wound closure 2ry patency at 1 year:-
Figure (4) 2ry patency rate We had registered 17 cases of graft thrombosis - 5 cases of thrombosis of both inflow and outflow grafts, 9 cases of thrombosed outflow grafts, and 3 cases of thrombosed inflow grafts. Re-operation consisted of revision or thrombectomy of the inflow graft. All 5 cases of thrombosis of inflow and outflow grafts were operated and restoration of blood flow in both grafts was attempted. In 9 cases, we registered isolated occlusion of the outflow grafts. In 3 cases, it was detected during routine examination and there was no evidence of critical ischemia of the limb. In these cases, surgery was not offered. In 6 cases of isolated occlusion of the outflow graft, angiography was done. Revascularization was attempted in 12 cases and was successful in 5 cases. The secondary graft patency rate was 60% in Group A and 28.6% in Group B after one year. The difference between the groups was not statistically significant after follow-up (P=0.56).
Complications:- Vessel perforation occurred in three patients, one in anterior tibial artery (ATA) and two in posterior tibial artery (PTA), and all were managed by prolonged balloon inflation. Mortality There was one early postoperative ( Amputation Minor and major limb loss were shown inTable ,8).
Table (7) Minor limb loss
Table (3) Major limb loss
Above-knee amputation was done for 8 (20%) patients and below-knee amputation for 5 (12.5%) patients in our study. Group A showed lower amputation rate but non-significantly different with group B (P=0.5). Practical results:- The disappearance of ischemic rest pain and healing of gangrenous and trophic ulcers after minor (toes or trans-metatarsal) amputations or debridement was considered as a positive result. A total amount of 40 minor amputations or debridement were performed after reconstructive surgery. In all; significant improvement was achieved in patients with functioning grafts. Three diabetic patients, despite functioning grafts, lost their limbs because of widespread infection of the foot. Postoperative improvement of ABI was regarded as an objective indication of improved perfusion of the limb. ABI increased from 0.29% before the operation to 0.89% in Group A and from 0.37% to 0.63% after inflow and to 0.85% after outflow procedures in Group B. The difference between the groups was statistically significant (P=0.047).
DISCUSSION Surgical treatment of CLI is based on correction of the most affected segment. Identification of hemodynamically significant arterial lesions can be difficult in the presence of multilevel disease.1 We tried to select the criteria for multi-segmental reconstruction based on simple, most widely used and inexpensive clinical vascular laboratory and angiographic findings as in Langsfeld et al, Taylor et al.5 In case of critical limb ischemia, many authors as Baker et al, Flanigan et al indicate the importance of the extent of disease in the deep femoral artery which forms the main collateral network in the presence of superficial femoral artery occlusion. Occlusion of diffuse diseased PFA is one of the most important indications to perform multi-segmental reconstruction.6,7 Diabetic vasculopathy is the most common reason of mortality and morbidity in diabetes and is responsible for high incidence of vascular diseases such as stroke, myocardial-infarction, and peripheral vascular diseases.8
Diabetics are up to 15 times more likely than non-diabetics to experience a major amputation. Diabetes is also associated with decreased primary patency following endovascular interventions. Endovascular interventions for CLI continue to have variable reported results, adequate rates of limb salvage can be achieved in patients undergoing multilevel interventions for CLI, and improved patency is seen with multilevel compared with isolated tibial interventions.8 On the other hand, there is no doubt that healing of the foot in the presence of tissue loss and gangrene requires close to normal blood supply in the damaged area. Some authors indicate that in these conditions, postoperative ABI index is supposed to be raised to 0.80 or more. We believe that patients with tissue loss of the foot and the presence of multilevel occlusive disease are the most serious candidates for multi-segmental reconstructive surgery.8 Our study included 40 patients of different age and sex suffering from multi-segment peripheral arterial disease. A total number of 56 multi-segmental reconstructions were performed for 40 patients (sixteen had bilateral procedures) for treatment of critical limb ischemia due to multi segmental occlusive arterial disease. In 20 cases, revascularization was performed in one stage (Group A) and in 20 cases - as a two-stage procedure (Group B). All patients enrolled in our study had associated comorbidities and risk factors (e.g. Diabetes, hypertension, ischemic heart disease, smoking, renal impairment, stroke, or chest disease), which were presented in the study as numbers of comorbidities and risk factors for each patient. Among our 40 patients with critical lower limb ischemia success rate after total revascularization (group A) reaching 82.5% success rate. Success rate after staged revascularization (group B) reaching 65% success rate from inflow cases and 66.7% of the outflow repair. We achieved a limb salvage rate of 67.5% (27 patients). With 15 patients (75%) in group A and 12 patients (60%) for group B and a major amputation rate of 32.5% (13 patients) over 1-year follow-up period. During the observation period, a total number of 5 limbs were lost (25%) in Group A and 8 (40%) in Group B. The difference between the groups was not statistically significant.
Dalman et al. presents a 90% limb salvage rate at the 36 month follow-up period in his group of 62 patients. It needs to be noted that 20% of patients in this group were operated on for claudication.10 Charlesworth et al. demonstrates excellent limb salvage rates in his series of 153 patients. During a five-year follow-up period, only seven limbs were lost. But in this group, patients were selected for aorto-femoro-popliteal reconstruction only in ischemic rest pain; patients with gangrene were not included. Not a single femoro-tibial bypass was performed in this group.10 Batt et al., in his series of 31 patients, reported five early amputations (16.1%) and at the end of the study of 48 months, seven limbs were lost (22.5%). Kram et al. presents a 78% five-year limb salvage rate after unilateral aorto-femoro-popliteal distal bypass. Ellenby et al. presented with a 77% limb salvage rate at five years in a group of 21 patients after femoro-popliteal bypass .9,11 We also found that increasing numbers of risk factors and comorbidities had drawback on the primary patency rate at 3 month and 12 month and on limb salvage rates with increase in the amputation rate. Abularrage et al. reviewed that diabetes mellitus is an independent predictor of decreased long-term primary patency after PTA/stent in 920 patients who underwent 1075 PTA/stent procedures, and long-term limb salvage remains inferior in diabetic patients compared with non-diabetic patients owing to a more severe clinical presentation and poor run-off .12,19 In his study considered superficial femoral plus iliac lesions in addition to age, dialysis, left ventricular dysfunction, diabetes, hematoma prolonging hospitalization, and coronary artery disease as positive predictors of all-cause mortality. Similar to our results, two studies of patients with multilevel lower limb arterial disease showed significantly improved secondary patency rates of multilevel intervention compared with single-level intervention. Sadek et al. in a study for treatment of multilevel lower limb arterial lesions on 85 patients mentioned a limb salvage rate of 76.1%, similar to our limb salvage rate of 75% in their group A patients showed significantly higher limb salvage rate and significant lower amputation rate than group B. Fernandez et al. showed a limb salvage rate of 95% for multi-level arterial lesions (P=0.05) .21
Wound healing was achieved in 75% in group A and 60% in group B with multilevel disease at 1 year. (P=0.05). Guo et al. in a study including 53 patients with TASC II D femoro popliteal occlusive disease showed a technical success rate of 95% with mean follow-up period of 12.2±6.1 months (5–38 months). Primary patency rate at 1 year was 63%, and secondary patency rate at 1year was 96%. These results were significantly better than our results because they included lesions in femoro popliteal segment only which was treated mainly by primary stenting whereas other levels of arterial lesion were not included. We also noticed that patients who presented with minor tissue loss or rest pain showed significantly higher limb salvage rates whereas patients who presented with major tissue loss or heal ulcer showed higher amputation rates. These findings were reported before in a study by Ghoneim et al. The primary graft patency rate was 65% in Group A and 50% in Group B after one year. The difference between the groups was not statistically significant (P=0.98). Graft patency rates observed by Dalman et al. were 92.6% for inflow grafts and 94.9% for outflow grafts after 24 months. Eidt et al. present a 94% aorto-femoral graft patency rate after five years, while femoro-popliteal graft patency rate was 80% for the saphenous vein after four years and 50% for polytetrafluoroethylene (PTFE) grafts after two years .10 Batt et al. (9) presents a 40% bypass patency rate at four years. Using an extra-peritoneal iliac endarterectomy as an inflow procedure combined with femoro-popliteal/tibial bypass, Taylor et al. achieved 100% patency of the iliac artery and an 87% outflow patency rate at six years. After –femoro-popliteal reconstruction, Ellenby et al. presented a 40% patency rate of the femoro-popliteal segment after five years.11 The secondary graft patency rate was 60% in Group A and 28.6% in Group B after one year. The difference between the groups was not statistically significant after one year of follow-up (P=0.56). Reintervention was needed in 12 patients owing to restenosis or total occlusion of the treated lesions presenting with either lost pulses, rest pain, or deterioration of the wound healing. The secondary patency rates were non statistically significant between group and group B at 12 months (3 patients 60%, 2 patients 28.6%). We had registered 17 cases of graft thrombosis - 5 cases of thrombosis of both inflow and outflow grafts, 9 cases of thrombosed outflow grafts, and 3 cases of thrombosed inflow grafts. Re-operation consisted of revision or thrombectomy of the inflow graft. All 5 cases of thrombosis of inflow and outflow grafts were operated and restoration of blood flow in both grafts was attempted. In 9 cases, we registered isolated occlusion of the outflow grafts. In 3 cases, it was detected during routine examination and there was no evidence of critical ischemia of the limb. In these cases, surgery was not offered. In 6 cases of isolated occlusion of the outflow graft, angiography was done. Our results are favorably comparable with those of other authors as Batt M et al, Eidt J et al, O'Donnel et al.10,20 Active surgical treatment of occluded grafts is now the accepted standard for vascular surgeons. Cheshire et al., in a series of 395 patients operated on for CLI, found that failure to re-intervene after primary graft failure would reduce limb salvage at three years to 70%. We fully support authors' opinions Ellenby et al, Harrington et al, Kram et al regarding aggressive re-interventions in the presence of graft failure. In most cases, when the patient presented with ischemia of the limb due to graft thrombosis, an operation to restore the blood flow was attempted.11 Vessel perforation occurred in three patients, one in anterior tibial artery (ATA) and two in posterior tibial artery (PTA), and all were managed by prolonged balloon inflation. There was one early postoperative ( Above-knee amputation was done for 8 (20%) patients and below-knee amputation for 5 (12.5%) patients in our study. Group A showed lower amputation rate but non-significantly different with group B (P=0.5). The disappearance of ischemic rest pain and healing of gangrenous and trophic ulcers after minor (toes or trans-metatarsal) amputations or debridement was considered as a positive result. A total amount of 40 minor amputations or debridements were performed after reconstructive surgery. In all; significant improvement was achieved in patients with functioning grafts.
Three diabetic patients, despite functioning grafts, lost their limbs because of widespread infection of the foot.
Postoperative improvement of ABI was regarded as an objective indication of improved perfusion of the limb. ABI increased from 0.29% before the operation to 0.89% in Group A and from 0.37% to 0.63% after inflow and to 0.85% after outflow procedures in Group B. The difference between the groups was statistically significant (P=0.047). CONCLUSIONS We can outline that in patients with multiple levels of arterial diseases, all efforts should be exerted to achieve total correction of all lesions to secure good in-line pulsatile flow to the foot. As it is associated with better primary and secondary patency rates and significantly higher limb salvage rates than correction of the proximal arterial lesions only. We conclude that multi-segmental reconstructions for multilevel occlusive arterial disease is a safe and effective method of treatment in the presence of CLI. Perioperative mortality, limb salvage and graft patency rates are better in the group of simultaneous reconstructions. Correction of the proximal lesions only cannot be considered satisfactory especially in patients presenting with tissue loss as it is usually associated with inferior patency rates and low overall limb salvage rates. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| References | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
1- Norgren L and William R: Inter-society consensus for the management of peripheral arterial disease (TASC II Eur.J.Vasc.Endovasc.Surg.,2007, 43:. 71-75 2- Pattillo, C. B., Bir, S., Rajaram, V and Kevil, C. G Inorganic nitrite and chronic tissue ischaemia: a novel therapeutic modality for peripheral vascular diseases. Cardiovascular Research, 2011, 89: pp. 533–41. doi:10.1093/cvr/cvq297. 3- Joost A Bekken, Jan Albert Vos, Ruud A Aarts, Jean-Paul PM de Vries and Bram Fioole Department of Vascular Surgery, Rotterdam, 2012, 3079 DZ, the Netherlands. 4- Abularrage CJ, Conrad MF, Hackney LA, Paruchuri V, Crawford RS, Kwolek CJ, et al. Long-outcomes of diabetic patients undergoing endovascular infrainguinal interventions term. J Vasc Surg 2010; 52:314–322. 5- Taylor LM Jr, Freimanis IE, Edwards JM, et al. Extraperitoneal iliac endarterectomy in the treatment of multilevel lower extremity arterial occlusive disease. Am J Surg 2015;152:34-9. 6- Baker JD. Hemodynamic assessment of aortoiliac segment. Surg Clin N Am 2010;70:31-40. 7- Flanigan DP, Ryan TJ, Williams LR, et al. Aortofemoral or femoropopliteal revascularization? A prospective evaluation of the papaverine test. J Vasc Surg 2006;1:215-23. 8- Flanigan DP, Williams LR, Scwartz JA, et al. Hemodynamic evaluation of the aortoiliac system based on pharmacologic vasodilation. J Vasc Surg 2012;93:709-14. 9- Batt M, Declemy S, Persch M, et al. Synchronous reconstruction for combined aortoiliac and femoropopliteal occlusive lesions. J Cardiovasc Surg 2010;31:448-52. 10- Eidt J, Charlesworth D. Combined aortobifemoral and femoropopliteal bypass in the management of patients with extensive atherosclerosis. Ann Vasc Surg 2008;1:453-60. 11- Ellenby MI, Sawchuk AP, Scwarcz TH, et al. A nine year experience with crossover femorofemoropopliteal sequential bypass. Am J Surg 2011;161:672-6. 12- Fernandez N, McEnaney R, Marone LK, Rhee RY, Leers S, Makaroun M, Chaer RA. Multilevel versus isolated endovascular tibial interventions for critical limb ischemia. J Vasc Surg 2011; 54:722–729. 13- Ghoneim B, Elwan H, Eldaly W, Khairy H, Taha A, Gad A. Management of critical lower limb ischemia in endovascular era: experience from 511 patients. Int J Angiol 2014; 23:197–206. 14- Guo X, Shi Y, Huang X, Ye M, Xue G, Zhang J. Features analysis of lower extremity arterial lesions in 162 diabetes patients. J Diabetes Res 2013; 2013:781360. 15- Guo X, Xue G, Huang X, Xie H, Liang W, Zhang J, et al. Outcomes of endovascular treatment for patients with TASC II D Femoropopliteal occlusive disease: a single center study. BMC Cardiovasc Disord 2015; 15:44–50. 16- Harrington ME, Harrington EB, Haimov M, et al. Iliofemoral versus femorofemoral bypass: the case for an individualized approach. J Vasc Surg 2013;16:841-54. 17- Kram HB, Gupta SK, Veith FJ, et al. Unilateral aortofemoral bypass: a safe and effective option for the treatment of unilateral limb-threatening ischemia. Am J Surg 2010;162:155-8. 18- Langsfeld M, Nepute J, Hershey FB, et al. The use of duplex scanning to predict hemodynamically significant Aortoiliac stenoses. J Vasc Surg 2007;7:395-9. 19- Miura T, Soga Y, Miyashita Y, Iida O, Kawasaki D, Hirano K, et al. Five-year prognosis after endovascular therapy in claudicant patients with iliofemoral artery disease. J Endovasc Ther 2014; 21:381–388. 20- O'Donnel FT Jr, McBride KA, Callow AD, et al. Management of combined segment disease. Am J Surg 1981;141:452-9. 21- Sadek M, Ellozy SH, Turnbull IC, Lookstein RA, Marin ML, Faries PL. Improved outcomes are associated with multilevel endovascular intervention involving the tibial vessels compared with isolated tibial intervention. J Vasc Surg 2009; 49:638–643. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Statistics Article View: 217 PDF Download: 308 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
